Aster DM Healthcare Ltd

  • BSE Code : 540975
  • NSE Symbol : ASTERDM
  • ISIN : INE914M01019
  • Industry :HEALTHCARE

up-arrow 749.05 0.15(0.02%)

Open Price ()

745.60

Prev. Close ()

748.90

Volume (No’s)

56,676

Market Cap ()

38,802.08

Low Price ()

742.05

High Price ()

752.75

 

Board Meetings

Start Date End Date Purpose
25-Apr-2026 30-Apr-2026 Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 inter alia to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31 2026 Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 ,inter alia, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 (As Per BSE Announcement Dated On : 25.04.2026) Outcome of the Board Meeting held on April 30, 2026 (As per BSE Announcement dated on: 30.04.2026)
20-Mar-2026 26-Mar-2026 Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2026 ,inter alia, to consider and approve declaration of interim dividend for FY 2025-26. The record date for payment of interim dividend, if declared, will be Friday, April 3, 2026 Outcome of Board Meeting held on March 26, 2026 - Declared interim dividend for FY 2025-26 (As per BSE Announcement dated on: 26.03.2026)
10-Mar-2026 10-Mar-2026 Outcome of Board meeting held on March 10, 2026
23-Jan-2026 30-Jan-2026 Employees Stock Option Plan & Quarterly Results Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve Board Meeting intimation for Q3 FY 2025-26 Intimation of outcome of Board meeting held on January 30, 2026 (As Per BSE Announcement Dated On : 30.01.2026)
31-Oct-2025 06-Nov-2025 Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve Quarterly Results and Other Matters Outcome of Board Meeting - Approval of financial results for the quarter ended September 2025 and other business matters (As Per BSE Announcement Dated on 06.11.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew